Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Cyberbiosecurity: A Call for Cooperation in a New Threat Landscape.

Richardson LC, Connell ND, Lewis SM, Pauwels E, Murch RS.

Front Bioeng Biotechnol. 2019 Jun 6;7:99. doi: 10.3389/fbioe.2019.00099. eCollection 2019.

2.

Susceptibility of Virulent Yersinia pestis Bacteria to Predator Bacteria in the Lungs of Mice.

Russo R, Kolesnikova I, Kim T, Gupta S, Pericleous A, Kadouri DE, Connell ND.

Microorganisms. 2018 Dec 21;7(1). pii: E2. doi: 10.3390/microorganisms7010002.

3.

Multistate Infestation with the Exotic Disease-Vector Tick Haemaphysalis longicornis - United States, August 2017-September 2018.

Beard CB, Occi J, Bonilla DL, Egizi AM, Fonseca DM, Mertins JW, Backenson BP, Bajwa WI, Barbarin AM, Bertone MA, Brown J, Connally NP, Connell ND, Eisen RJ, Falco RC, James AM, Krell RK, Lahmers K, Lewis N, Little SE, Neault M, Pérez de León AA, Randall AR, Ruder MG, Saleh MN, Schappach BL, Schroeder BA, Seraphin LL, Wehtje M, Wormser GP, Yabsley MJ, Halperin W.

MMWR Morb Mortal Wkly Rep. 2018 Nov 30;67(47):1310-1313. doi: 10.15585/mmwr.mm6747a3.

4.

Keeping it together: absence of genetic variation and DNA incorporation by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus during predation.

Gupta S, Lemenze A, Donnelly RJ, Connell ND, Kadouri DE.

Res Microbiol. 2018 May - Jun;169(4-5):237-243. doi: 10.1016/j.resmic.2018.03.002. Epub 2018 May 8.

PMID:
29751066
5.

The Challenge of Global Catastrophic Biological Risks.

Connell ND.

Health Secur. 2017 Jul/Aug;15(4):345-346. doi: 10.1089/hs.2017.0056. Epub 2017 Jul 24. No abstract available.

6.

Examining the efficacy of intravenous administration of predatory bacteria in rats.

Shatzkes K, Singleton E, Tang C, Zuena M, Shukla S, Gupta S, Dharani S, Rinaggio J, Kadouri DE, Connell ND.

Sci Rep. 2017 May 12;7(1):1864. doi: 10.1038/s41598-017-02041-3.

7.

Predatory bacteria: a new therapeutic approach for a post-antibiotic era.

Shatzkes K, Connell ND, Kadouri DE.

Future Microbiol. 2017 May;12:469-472. doi: 10.2217/fmb-2017-0021. Epub 2017 May 8. No abstract available.

PMID:
28481158
8.

Effect of predatory bacteria on the gut bacterial microbiota in rats.

Shatzkes K, Tang C, Singleton E, Shukla S, Zuena M, Gupta S, Dharani S, Rinaggio J, Connell ND, Kadouri DE.

Sci Rep. 2017 Mar 6;7:43483. doi: 10.1038/srep43483.

9.

Predatory Bacteria Attenuate Klebsiella pneumoniae Burden in Rat Lungs.

Shatzkes K, Singleton E, Tang C, Zuena M, Shukla S, Gupta S, Dharani S, Onyile O, Rinaggio J, Connell ND, Kadouri DE.

MBio. 2016 Nov 8;7(6). pii: e01847-16. doi: 10.1128/mBio.01847-16.

10.

A Course on Terror Medicine: Content and Evaluations.

Cole LA, Natal B, Fox A, Cooper A, Kennedy CA, Connell ND, Sugalski G, Kulkarni M, Feravolo M, Lamba S.

Prehosp Disaster Med. 2016 Feb;31(1):98-101. doi: 10.1017/S1049023X15005579. Epub 2016 Jan 11.

PMID:
26751384
11.

Avalanche for shape and feature-based virtual screening with 3D alignment.

Diller DJ, Connell ND, Welsh WJ.

J Comput Aided Mol Des. 2015 Nov;29(11):1015-24. doi: 10.1007/s10822-015-9875-y. Epub 2015 Oct 12.

PMID:
26458937
12.

Examining the safety of respiratory and intravenous inoculation of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus in a mouse model.

Shatzkes K, Chae R, Tang C, Ramirez GC, Mukherjee S, Tsenova L, Connell ND, Kadouri DE.

Sci Rep. 2015 Aug 7;5:12899. doi: 10.1038/srep12899.

13.

Susceptibility of Select Agents to Predation by Predatory Bacteria.

Russo R, Chae R, Mukherjee S, Singleton EJ, Occi JL, Kadouri DE, Connell ND.

Microorganisms. 2015 Dec 2;3(4):903-12. doi: 10.3390/microorganisms3040903.

14.

Terror medicine as part of the medical school curriculum.

Cole LA, Wagner K, Scott S, Connell ND, Cooper A, Kennedy CA, Natal B, Lamba S.

Front Public Health. 2014 Sep 12;2:138. doi: 10.3389/fpubh.2014.00138. eCollection 2014. Review.

15.

Validation of high throughput sequencing and microbial forensics applications.

Budowle B, Connell ND, Bielecka-Oder A, Colwell RR, Corbett CR, Fletcher J, Forsman M, Kadavy DR, Markotic A, Morse SA, Murch RS, Sajantila A, Schmedes SE, Ternus KL, Turner SD, Minot S.

Investig Genet. 2014 Jul 30;5:9. doi: 10.1186/2041-2223-5-9. eCollection 2014. Review.

16.

Engaging actively with issues in the responsible conduct of science: lessons from international efforts are relevant for undergraduate education in the United States.

Clements JD, Connell ND, Dirks C, El-Faham M, Hay A, Heitman E, Stith JH, Bond EC, Colwell RR, Anestidou L, Husbands JL, Labov JB.

CBE Life Sci Educ. 2013 Winter;12(4):596-603. doi: 10.1187/cbe.13-09-0184.

17.

Effects by anthrax toxins on hematopoiesis: a key role for cytokines as mediators.

Rameshwar P, Wong EW, Connell ND.

Cytokine. 2012 Jan;57(1):143-9. doi: 10.1016/j.cyto.2011.10.013. Epub 2011 Nov 13.

PMID:
22082805
18.

Control of mycobacterium tuberculosis infection by glutathione.

Connell ND, Venketaraman V.

Recent Pat Antiinfect Drug Discov. 2009 Nov;4(3):214-26. Review.

PMID:
19832692
19.

Non-canonical effects of anthrax toxins on haematopoiesis: implications for vaccine development.

Liu K, Wong EW, Schutzer SE, Connell ND, Upadhyay A, Bryan M, Rameshwar P.

J Cell Mol Med. 2009 Aug;13(8B):1907-19. doi: 10.1111/j.1582-4934.2008.00477.x. Epub 2008 Dec 10.

20.

Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.

Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB.

Microb Pathog. 2008 Sep;45(3):173-80. doi: 10.1016/j.micpath.2008.05.007. Epub 2008 Jun 5.

21.

Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis.

Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V.

J Interferon Cytokine Res. 2008 Mar;28(3):153-65. doi: 10.1089/jir.2007.0095.

PMID:
18338948
22.

Glutathione levels and immune responses in tuberculosis patients.

Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, Lardizabal A, David Hom, Connell ND.

Microb Pathog. 2008 Mar;44(3):255-61. Epub 2007 Sep 26.

PMID:
17959342
23.

Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection.

Talaue MT, Venketaraman V, Hazbón MH, Peteroy-Kelly M, Seth A, Colangeli R, Alland D, Connell ND.

J Bacteriol. 2006 Jul;188(13):4830-40.

24.

Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells.

Boniotto M, Jordan WJ, Eskdale J, Tossi A, Antcheva N, Crovella S, Connell ND, Gallagher G.

Antimicrob Agents Chemother. 2006 Apr;50(4):1433-41.

25.

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects.

Venketaraman V, Rodgers T, Linares R, Reilly N, Swaminathan S, Hom D, Millman AC, Wallis R, Connell ND.

AIDS Res Ther. 2006 Feb 20;3:5.

26.
27.

Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro.

Freeman S, Post FA, Bekker LG, Harbacheuski R, Steyn LM, Ryffel B, Connell ND, Kreiswirth BN, Kaplan G.

J Interferon Cytokine Res. 2006 Jan;26(1):27-33.

PMID:
16426145
28.

Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis.

Venketaraman V, Dayaram YK, Talaue MT, Connell ND.

Infect Immun. 2005 Mar;73(3):1886-9.

29.

Molecular beacons for multiplex detection of four bacterial bioterrorism agents.

Varma-Basil M, El-Hajj H, Marras SA, Hazbón MH, Mann JM, Connell ND, Kramer FR, Alland D.

Clin Chem. 2004 Jun;50(6):1060-2. No abstract available.

30.

Nitric oxide regulation of L-arginine uptake in murine and human macrophages.

Venketaraman V, Talaue MT, Dayaram YK, Peteroy-Kelly MA, Bu W, Connell ND.

Tuberculosis (Edinb). 2003;83(5):311-8.

PMID:
12972344
31.

Role of glutathione in macrophage control of mycobacteria.

Venketaraman V, Dayaram YK, Amin AG, Ngo R, Green RM, Talaue MT, Mann J, Connell ND.

Infect Immun. 2003 Apr;71(4):1864-71.

32.

Modulation of J774.1 macrophage L-arginine metabolism by intracellular Mycobacterium bovis BCG.

Peteroy-Kelly MA, Venketaraman V, Talaue M, Seth A, Connell ND.

Infect Immun. 2003 Feb;71(2):1011-5.

33.

Bioweapon agents: more access means more risk.

Ebright RH, Connell ND.

Nature. 2002 Jan 24;415(6870):364. No abstract available.

PMID:
11807521
34.

Expression systems for use in actinomycetes and related organisms.

Connell ND.

Curr Opin Biotechnol. 2001 Oct;12(5):446-9. Review.

PMID:
11604318
36.

Characterization of a Mycobacterium smegmatis mutant that is simultaneously resistant to D-cycloserine and vancomycin.

Peteroy M, Severin A, Zhao F, Rosner D, Lopatin U, Scherman H, Belanger A, Harvey B, Hatfull GF, Brennan PJ, Connell ND.

Antimicrob Agents Chemother. 2000 Jun;44(6):1701-4.

38.

Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region.

Kurepina NE, Sreevatsan S, Plikaytis BB, Bifani PJ, Connell ND, Donnelly RJ, van Sooligen D, Musser JM, Kreiswirth BN.

Tuber Lung Dis. 1998;79(1):31-42.

PMID:
10645440
39.
40.

A mutant of Mycobacterium smegmatis defective in dipeptide transport.

Bhatt A, Green R, Coles R, Condon M, Connell ND.

J Bacteriol. 1998 Dec;180(24):6773-5.

41.

Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.

Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM.

Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74.

42.

Interruption of the phosphoglucose isomerase gene results in glucose auxotrophy in Mycobacterium smegmatis.

Tuckman D, Donnelly RJ, Zhao FX, Jacobs WR Jr, Connell ND.

J Bacteriol. 1997 Apr;179(8):2724-30.

43.

Mycobacterium: isolation, maintenance, transformation, and mutant selection.

Connell ND.

Methods Cell Biol. 1994;45:107-25. Review. No abstract available.

PMID:
7707982
44.

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.

Connell ND, Medina-Acosta E, McMaster WR, Bloom BR, Russell DG.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11473-7.

45.

Recombinant BCG as a candidate oral vaccine vector.

Barletta RG, Snapper B, Cirillo JD, Connell ND, Kim DD, Jacobs WR, Bloom BR.

Res Microbiol. 1990 Sep-Oct;141(7-8):931-9.

PMID:
2101484
47.
48.

Effect of glucose uptake on growth rate of mouse 3T3 cells.

Romano AH, Connell ND.

J Cell Physiol. 1982 May;111(2):195-200.

PMID:
7085776
49.

6-deoxy-D-glucose and D-xylose: analogs for the study of D-glucose transport by mouse 3T3 cells.

Romano AH, Connell ND.

J Cell Physiol. 1982 Apr;111(1):77-82.

PMID:
7085771
50.

Transport of 6-deoxy-D-glucose and D-xylose by untransformed and SV40-transformed 3T3 cells.

Romano AH, Connell ND.

J Cell Physiol. 1982 Apr;111(1):83-8.

PMID:
6282906

Supplemental Content

Loading ...
Support Center